×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| AMRUTANJAN HEALTH CARE LTD. | 984.73 | 83.11 | 940.46 | 2.87 | 2,208 | 108.0 |
| SMS PHARMACEUTICALS LTD. | 1966.4 | 182.07 | 1960.47 | 2.05 | 2199 | 30.1 |
| Windlas Biotech Limited | 2153.29 | 176.64 | 2100.9 | 8.34 | 2123 | 32.6 |
Amrutanjan Health Care Limited, with Security Code 590006, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100.3 | 77.9 | 99.3 | 117.0 | 127.1 | 83.7 | 109.9 | 122.8 | 135.4 | 94.0 |
| Expenses | 87.3 | 70.7 | 92.5 | 95.4 | 110.8 | 80.2 | 96.3 | 99.4 | 117.7 | 85.6 |
| Operating Profit | 13.0 | 7.2 | 6.8 | 21.6 | 16.2 | 3.5 | 13.6 | 23.3 | 17.7 | 8.4 |
| OPM % | 12.94% | 9.19% | 6.89% | 18.44% | 12.78% | 4.24% | 12.37% | 19.02% | 13.07% | 8.98% |
| Other Income | 4.8 | 3.7 | 3.9 | 3.8 | 5.0 | 4.5 | 4.0 | 4.4 | 4.8 | 4.4 |
| Interest | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 |
| Depreciation | 1.3 | 1.4 | 1.6 | 1.6 | 1.5 | 1.6 | 1.7 | 1.7 | 1.6 | 1.5 |
| Profit before tax | 16.5 | 9.4 | 9.2 | 23.7 | 19.6 | 6.3 | 15.9 | 26.0 | 20.9 | 11.3 |
| Tax % | -22.9% | -25.6% | -25.6% | -26.4% | -30.3% | -27.3% | -26% | -25.9% | 27.2% | 26.4% |
| Net Profit | 12.7 | 7.0 | 6.8 | 17.5 | 13.7 | 4.6 | 11.8 | 19.2 | 15.2 | 8.3 |
| EPS in Rs | 4.34 | 2.39 | 2.36 | 6.04 | 4.72 | 1.6 | 4.08 | 6.66 | 5.25 | 2.87 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 12% |
| 3 Years: | 4% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 15% |
| 3 Years: | -9% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 17% |
| 3 Years: | -4% |
| 1 Year: | -2% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 11% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 27% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 17% |
| 3 Years: | -4% |
| 1 Year: | -2% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|